세계의 임상시험 이미징 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for clinical trial imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global clinical trial imaging market from 2025 to 2032.

Key Insights:

• Clinical Trial Imaging Market Size (2025E): US$ 1.5 Bn
• Projected Market Value (2032F): US$ 2.5 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 7.5%

Clinical Trial Imaging Market - Report Scope:

Clinical trial imaging refers to the use of medical imaging techniques such as MRI, CT scans, PET scans, and ultrasound in clinical trials to assess the efficacy and safety of new drugs, treatments, and medical devices. These imaging modalities help researchers in accurate disease diagnosis, treatment monitoring, and biomarker identification. The demand for clinical trial imaging is rising as pharmaceutical and biotechnology companies increasingly rely on imaging-based evidence to support regulatory approvals and accelerate drug development timelines.

Market Growth Drivers:

The global clinical trial imaging market is driven by several key factors, including the growing adoption of advanced imaging technologies in clinical research. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has fueled the demand for imaging-based biomarkers in drug trials. Moreover, the rising number of clinical trials globally, coupled with stringent regulatory requirements for imaging endpoints, is propelling market growth. Advancements in artificial intelligence (AI) and machine learning (ML) integration with imaging technologies are further enhancing image analysis accuracy, thus improving clinical trial outcomes.

Market Restraints:

Despite significant growth opportunities, the clinical trial imaging market faces challenges such as high costs associated with imaging modalities and infrastructure. The complexity of regulatory compliance in different regions also acts as a barrier to market expansion. Additionally, the shortage of skilled professionals for imaging data interpretation and analysis poses a challenge for efficient clinical trial execution. Delays in trial approvals and the variability in imaging protocols across different study sites further add to the operational complexities of this market.

Market Opportunities:

The clinical trial imaging market presents substantial growth opportunities driven by the increasing adoption of cloud-based imaging solutions and remote monitoring technologies. The development of AI-powered imaging software is expected to enhance real-time data processing and automate image analysis, reducing human errors. Additionally, strategic collaborations between pharmaceutical companies, contract research organizations (CROs), and imaging service providers are expected to streamline clinical trial imaging workflows. The expansion of clinical trials in emerging markets, particularly in Asia-Pacific, offers lucrative growth prospects for market players.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the clinical trial imaging market globally?
• How does the integration of AI and machine learning enhance imaging capabilities in clinical trials?
• Which therapeutic areas are leading in the adoption of clinical trial imaging solutions?
• Who are the key players in the clinical trial imaging market, and what strategies are they employing to gain a competitive advantage?
• What are the emerging trends and future growth prospects in the global clinical trial imaging market?

Competitive Intelligence and Business Strategy:

Leading players in the global clinical trial imaging market, including BioTelemetry, Parexel International Corporation, ICON plc, Medpace, and Biomedical Systems, focus on technological innovations, strategic partnerships, and service expansion to strengthen their market presence. Companies are investing in AI-driven imaging analysis platforms and cloud-based imaging solutions to improve clinical trial efficiency. Collaborations with pharmaceutical firms and CROs are facilitating the seamless integration of imaging endpoints in drug development studies. The increasing adoption of decentralized trials and remote imaging solutions is also shaping the future of clinical trial imaging, ensuring faster and more cost-effective trial execution.

Key Companies Profiled:

• Ixico PLC
• Navitas Life Sciences
• Resonance Health
• Radiant Sage LLC
• Medpace
• WCG Clinical
• Icon PLC
• Voiant
• Clario
• Parexel International Corporation
• Anagram
• Calyx
• Invicro

Clinical Trial Imaging Market Segmentation

By Product & Services

• Services
• Software

By Modality

• CT scan
• MRI
• X-Ray
• Ultrasound

By Therapeutic Area

• Oncology
• Neurology
• Cardiology
• Orthopedics
• Obstetrics & Gynecology

By End User

• Contract Research Organizations (CROs)
• Pharmaceutical & Biotechnology Companies
• Academic and Government Research Institutes

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Clinical Trial Imaging Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product & Services Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2032

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product & Services Prices
• 4.3. Pricing Analysis By Product & Services
• 4.4. Regional Prices and Product & Services Preferences

5. Global Clinical Trial Imaging Market Outlook:

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Bn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 5.3. Global Clinical Trial Imaging Market Outlook: Product & Services
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product & Services, 2019-2024
  • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
    • 5.3.3.1. Services
    • 5.3.3.2. Software
• 5.4. Market Attractiveness Analysis: Product & Services
• 5.5. Global Clinical Trial Imaging Market Outlook: Modality
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2024
  • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 5.5.3.1. CT scan
    • 5.5.3.2. MRI
    • 5.5.3.3. X-Ray
• 5.6. Market Attractiveness Analysis: Modality
• 5.7. Global Clinical Trial Imaging Market Outlook: Therapeutic Area
  • 5.7.1. Introduction / Key Findings
  • 5.7.2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019-2024
  • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025-2032
    • 5.7.3.1. Oncology
    • 5.7.3.2. Neurology
    • 5.7.3.3. Cardiology
    • 5.7.3.4. Orthopedics
    • 5.7.3.5. Obstetrics & Gynecology
• 5.8. Market Attractiveness Analysis: Therapeutic Area
• 5.9. Global Clinical Trial Imaging Market Outlook: End User
  • 5.9.1. Introduction / Key Findings
  • 5.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By End User, 2019-2024
  • 5.9.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
    • 5.9.3.1. Contract Research Organizations (CROs)
    • 5.9.3.2. Pharmaceutical & Biotechnology Companies
    • 5.9.3.3. Academic and Government Research Institutes

6. Global Clinical Trial Imaging Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
• 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Clinical Trial Imaging Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Product & Services
  • 7.2.3. By Modality
  • 7.2.4. By Therapeutic Area
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
  • 7.4.1. Services
  • 7.4.2. Software
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 7.5.1. CT scan
  • 7.5.2. MRI
  • 7.5.3. X-Ray
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
  • 7.6.1. Oncology
  • 7.6.2. Neurology
  • 7.6.3. Cardiology
  • 7.6.4. Orthopedics
  • 7.6.5. Obstetrics & Gynecology
• 7.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
  • 7.7.1. Contract Research Organizations (CROs)
  • 7.7.2. Pharmaceutical & Biotechnology Companies
  • 7.7.3. Academic and Government Research Institutes
• 7.8. Market Attractiveness Analysis

8. Europe Clinical Trial Imaging Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Product & Services
  • 8.2.3. By Modality
  • 8.2.4. By Therapeutic Area
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
  • 8.4.1. Services
  • 8.4.2. Software
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 8.5.1. CT scan
  • 8.5.2. MRI
  • 8.5.3. X-Ray
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
  • 8.6.1. Oncology
  • 8.6.2. Neurology
  • 8.6.3. Cardiology
  • 8.6.4. Orthopedics
  • 8.6.5. Obstetrics & Gynecology
• 8.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
  • 8.7.1. Contract Research Organizations (CROs)
  • 8.7.2. Pharmaceutical & Biotechnology Companies
  • 8.7.3. Academic and Government Research Institutes
• 8.8. Market Attractiveness Analysis

9. East Asia Clinical Trial Imaging Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Product & Services
  • 9.2.3. By Modality
  • 9.2.4. By Therapeutic Area
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
  • 9.4.1. Services
  • 9.4.2. Software
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 9.5.1. CT scan
  • 9.5.2. MRI
  • 9.5.3. X-Ray
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
  • 9.6.1. Oncology
  • 9.6.2. Neurology
  • 9.6.3. Cardiology
  • 9.6.4. Orthopedics
  • 9.6.5. Obstetrics & Gynecology
• 9.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
  • 9.7.1. Contract Research Organizations (CROs)
  • 9.7.2. Pharmaceutical & Biotechnology Companies
  • 9.7.3. Academic and Government Research Institutes
• 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Clinical Trial Imaging Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Product & Services
  • 10.2.3. By Modality
  • 10.2.4. By Therapeutic Area
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
  • 10.4.1. Services
  • 10.4.2. Software
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 10.5.1. CT scan
  • 10.5.2. MRI
  • 10.5.3. X-Ray
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
  • 10.6.1. Oncology
  • 10.6.2. Neurology
  • 10.6.3. Cardiology
  • 10.6.4. Orthopedics
  • 10.6.5. Obstetrics & Gynecology
• 10.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
  • 10.7.1. Contract Research Organizations (CROs)
  • 10.7.2. Pharmaceutical & Biotechnology Companies
  • 10.7.3. Academic and Government Research Institutes
• 10.8. Market Attractiveness Analysis

11. Latin America Clinical Trial Imaging Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Product & Services
  • 11.2.3. By Modality
  • 11.2.4. By Therapeutic Area
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
  • 11.4.1. Services
  • 11.4.2. Software
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 11.5.1. CT scan
  • 11.5.2. MRI
  • 11.5.3. X-Ray
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
  • 11.6.1. Oncology
  • 11.6.2. Neurology
  • 11.6.3. Cardiology
  • 11.6.4. Orthopedics
  • 11.6.5. Obstetrics & Gynecology
• 11.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
  • 11.7.1. Contract Research Organizations (CROs)
  • 11.7.2. Pharmaceutical & Biotechnology Companies
  • 11.7.3. Academic and Government Research Institutes
• 11.8. Market Attractiveness Analysis

12. Middle East & Africa Clinical Trial Imaging Market Outlook:

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
  • 12.2.1. By Country
  • 12.2.2. By Product & Services
  • 12.2.3. By Modality
  • 12.2.4. By Therapeutic Area
• 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product & Services, 2025-2032
  • 12.4.1. Services
  • 12.4.2. Software
• 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
  • 12.5.1. CT scan
  • 12.5.2. MRI
  • 12.5.3. X-Ray
• 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area , 2025-2032
  • 12.6.1. Oncology
  • 12.6.2. Neurology
  • 12.6.3. Cardiology
  • 12.6.4. Orthopedics
  • 12.6.5. Obstetrics & Gynecology
• 12.7. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By End User, 2025-2032
  • 12.7.1. Contract Research Organizations (CROs)
  • 12.7.2. Pharmaceutical & Biotechnology Companies
  • 12.7.3. Academic and Government Research Institutes
• 12.8. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Ixico PLC
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Product & Services Types
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. Navitas Life Sciences
  • 13.3.3. Resonance Health
  • 13.3.4. Radiant Sage LLC
  • 13.3.5. Medpace
  • 13.3.6. WCG Clinical
  • 13.3.7. Icon PLC
  • 13.3.8. Voiant
  • 13.3.9. Clario
  • 13.3.10. Parexel International Corporation
  • 13.3.11. Anagram
  • 13.3.12. Calyx
  • 13.3.13. Invicro

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations